4.7 Review

p62 as a therapeutic target for tumor

期刊

出版社

ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.ejmech.2020.112231

关键词

Autophagy; p62/SQSTM1; mTORC1; NF-kappa B; Nrf2; Tumor

资金

  1. National Natural Science Foundation of China [81930100, 81773581, 81773639]
  2. Natural Science Foundation of Jiangsu Province of China [BK20160746]
  3. National Science & Technology Major Project Key New Drug Creation and Manufacturing Program, China [2018ZX09711002, 2017ZX09302003]
  4. Priority Academic Program Development of Jiangsu Higher Education Institutions
  5. Double First Class Innovation Team of China Pharmaceutical University [CPU2018GY02]
  6. Program for Outstanding Scientific and Technological Innovation Team of Jiangsu Higher Education
  7. Qing Lan Project of Jiangsu Province
  8. Young Elite Scientists Sponsorship Program by CAST

向作者/读者索取更多资源

p62/SQSTM1 (hereafter as p62) is a stress-inducible cellular protein, which interacts with various signaling proteins to regulate a variety of cellular functions. Growing lines of evidence supported a critical role of p62 in tumorigenesis, and p62 may become a therapeutic target for tumor. In this review, we summarize biological functions of structural domains of p62, reported bioactive molecules targeting p62, and the relationship between p62 and tumorigenesis. (c) 2020 Elsevier Masson SAS. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据